Breaks Categories: Stock Spotlights

ThursdayDec 09, 2021 2:29 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Study Marks First Phase 2 Trial to Evaluate Cannabinol as Therapeutic Option for Disease Treatment

InMed Pharmaceuticals (NASDAQ: INM) recently released its Q1 2022 financial results along with a business update showing positive momentum across all of its programs. Following the acquisition of BayMedica Inc. in October that created an industry leader in the manufacture and commercialization of rare cannabinoids, management expects to introduce multiple new, rare cannabinoids in the near future, focusing on high demand, attractive margin products. In late September, InMed commenced the 755-201-EB study, its phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders scientifically known as Epidermolysis Bullosa (“EB”). A recent article…

Continue Reading

ThursdayDec 09, 2021 2:05 pm

NetworkNewsBreaks – DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) AI Solution Helping Employers Identify Right Talent, Users Identify Personality Traits

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, is poised to benefit from the fact that AI technology may just be what companies need to make decisions on hiring the right talent and personality for a job. DIGI’s Projected Personality Interpreter (“PPI”), which was originally conceived and launched by Darwin Ecosystems, a company that was acquired by DigiMax late last year, evaluates a company’s workforce, brand and culture by revealing the personality traits and sentiments buried in human expression. “By leveraging IBM Watson and a customer algorithm that analyzes applicant responses across…

Continue Reading

ThursdayDec 09, 2021 12:57 pm

NetworkNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Milestones Highlight HealthTab’s Endless Diagnostic Possibilities

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has, since the company’s inception, been driven by the development of a network of point-of-care (“POC”) analyzers that run on its HealthTab(TM) software in community pharmacies, workplaces and rural areas. Earlier this year, the company signed a deal with Abbott to expand the distribution of its Affinion 2 analyzers in pharmacies. Shortly thereafter, Avricore also entered an agreement with Shoppers Drug Mart to stock HealthTab for diabetes screening in 11 different locations. “The company has recognized an opportunity and capitalizes on established consumer trends, technology advancements, health policy and industry changes to solve a…

Continue Reading

WednesdayDec 08, 2021 2:56 pm

NetworkNewsBreaks – Sharing Services Global Corporation (SHRG) Subsidiary Poised as Recognized Leader in Natural Nootropics

Sharing Services Global’s (OTCQB: SHRG) subsidiary the Happy Co., a direct-sales opportunity that offers functional beverages, capsules, patches and creams featuring nootropics, could witness significant benefit from the projected growth in the global nootropics market. A recent report projects that this space, which reached $2.42 billion in 2020, will top $6.29 billion by 2028, growing at a CAGR of 12.71% during the forecast period (https://nnw.fm/DfGgg). The report attributes the growth to the rise in demand for cognitive enhancers or smart drugs among the global population to enhance memory and stay focused. “One of the fastest-growing companies in the social-marketing and direct-selling…

Continue Reading

WednesdayDec 08, 2021 2:47 pm

NetworkNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Delivering Evidence-Based DTx, Research Centered Around Psychedelics

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (“MINDCURE”), a leader in advanced proprietary technology and research for psychedelics, recently released an operational update regarding the strategic initiatives of its operating segments – MINDCURE Research and MINDCURE Technology. The update detailed the company’s progress and plans for the immediate future. “As a member of the Digital Therapeutics Alliance, MINDCURE delivers digital therapeutics (‘DTx’) that are evidence-based interventions driven by high-quality software to prevent, manage and treat medical disorders,” reads a recent article. A leader in advanced proprietary technology and research centered around psychedelics, MINDCURE is currently advancing multiple programs and products…

Continue Reading

WednesdayDec 08, 2021 2:38 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Clinical Trials, Focus Puts It ‘In Pretty Rarefied Air’

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is advancing toward the launch of four phase 2a studies of its two novel drug candidates, TRP-8802 and TRP-8803, for treating fibromyalgia, phantom limb pain, complex regional pain syndrome (“CRPS”) and select eating disorders. Tryp filed an IND with the U.S. Food and Drug Administration in September for treating overeating disorders in Florida and filed its second IND application earlier in November for fibromyalgia testing in Michigan. The FDA asked the company to change the scope of its eating disorders trial so that the initial Florida investigation can focus on patients with binge eating…

Continue Reading

TuesdayDec 07, 2021 2:50 pm

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Focusing on Continued Growth of Top-Line Revenue, Bottom-Line Results

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has officially entered the second phase of a three-phase development strategy that captures its expansion plan in Florida after installing, commissioning and loading five of 30 planned modular grow pods, which are already growing plants. RWB, through its subsidiary Red White & Bloom Florida LLC (“RWBFL”), is fast-tracking the remaining 25 pods. Collectively, the 30 pods will provide about 19,000 square feet of operating space with an expected yield of 10,000 pounds of high-quality flower annually. RWB anticipates this annual yield will generate $30 million in additional revenue. RWBFL also successfully…

Continue Reading

TuesdayDec 07, 2021 2:26 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Positioned Amid Substantial Rise in Returns

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has seen a significant rise in its financial returns over the past year. “For the second quarter of fiscal 2021, the company reported Q2 revenues of $7.7 million, up 557% year-over-year, and rising by 41% quarter-on-quarter. The company also seized on the opportunity to update their corporate revenue guidance, increasing Q3 guidance to $8.3 million, which would represent at least a +7.7% quarter-on-quarter increase. SRAX also increased their full year revenue target to $32 million, up from $30…

Continue Reading

MondayDec 06, 2021 1:29 pm

NetworkNewsBreaks – Why Marijuana Company of America Inc. (MCOA) Is ‘One to Watch’

Marijuana Company of America (OTC: MCOA), which operates and invests in the cannabis sector directly, continues to grow its business. MCOA focuses on remaining fiscally conscious while further establishing itself in the legalized THC, hemp and CBD industries by offering unique exposure to the global cannabidiol sector. “The company intends to continue to leverage its premium brand hemp-based products with investments in and collaboration with existing and new strategic partners,” reads a recent article. “MCOA strives to develop a comprehensive selection of synergistic companies that provides consistent value to its shareholders. Furthermore, its vertically integrated business model provides companies and…

Continue Reading

MondayDec 06, 2021 1:05 pm

NetworkNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Aligning Long-Term Strategy to Position in Vertically Integrated Marketplace

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is taking strategic steps to ensure its position in the growing cannabis market in California. Within the sector, sales of legal adult-use cannabis are expected to reach roughly $7.2 billion by 2024, up from 2.5 billion in 2018, according to Statista (https://nnw.fm/EPebx). “Cannabis Strategic Ventures is aligning its long-term strategy with that growth in mind, as the company remains focused on shaping the future of the cannabis industry by striving for constant evolution in products, places and people,” reads a recent article. NUGS recently signed a memorandum of…

Continue Reading